Clinic
Allina Health System
Allina Health System was paid $7.56M by Medicaid between Jan 2018 and Dec 2024, across 133 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoALLINA HEALTH SYSTEM
FARIBAULT, MN 55021
FARIBAULT, MN 55021
33aNPI1013213826assigned 01/27/2011
33bProvider typeClinic/Center
28Total paid$7.56M
24GClaims242,652
24DCodes billed133
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Minnesota
Rank by total paid#7 of 250
Median peer was paid$274K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TALLARICO, DOMINICA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,317 | $418K | |
| 2019 | 45,248 | $1.45M | |
| 2020 | 38,238 | $1.30M | |
| 2021 | 43,569 | $1.50M | |
| 2022 | 32,239 | $1.20M | |
| 2023 | 24,149 | $987K | |
| 2024incomplete | 15,892 | $704K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 42,138 | 36,796 | $2.76M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 34,178 | 30,463 | $1.55M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 7.3% | 8,482 | 5,553 | $551K |
| X5622 | 4.2% | 4,387 | 4,224 | $315K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.7% | 2,855 | 2,812 | $202K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.5% | 7,172 | 7,020 | $192K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 2,033 | 1,961 | $157K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.9% | 1,876 | 1,833 | $147K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.9% | 2,836 | 2,745 | $142K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.2% | 1,000 | 969 | $93K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 1,282 | 1,269 | $92K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 1.1% | 2,920 | 2,611 | $84K |
121 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 6,526 | $79K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 23,926 | $78K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 572 | $66K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 12,385 | $59K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,445 | $50K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 664 | $49K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,856 | $47K |
| 92015 | Determination of refractive state | <1% | 3,936 | $46K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 820 | $43K |
| 90686 | <1% | 7,152 | $39K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,671 | $38K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,166 | $36K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,293 | $33K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,348 | $32K |
| 99188 | <1% | 3,608 | $28K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,771 | $28K |
| 92551 | <1% | 4,952 | $27K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,853 | $27K |
| 80061 | Lipid panel | <1% | 2,473 | $26K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 319 | $24K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,507 | $24K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,299 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,767 | $23K |
| 80053 | Comprehensive metabolic panel | <1% | 2,277 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 542 | $18K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,371 | $17K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 428 | $14K |
| 0001A | <1% | 632 | $14K | |
| 0002A | <1% | 531 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 769 | $12K |
| V2020 | Frames, purchases | <1% | 490 | $12K |
| 97803 | <1% | 272 | $11K | |
| 90691 | <1% | 95 | $10K | |
| 92567 | <1% | 968 | $10K | |
| 90717 | <1% | 80 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,255 | $9K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 153 | $9K |
| 85027 | <1% | 1,445 | $8K | |
| 91322 | <1% | 98 | $8K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 84 | $8K |
| 90651 | <1% | 490 | $8K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,102 | $7K |
| 92557 | <1% | 300 | $7K | |
| 81025 | <1% | 833 | $6K | |
| 99173 | <1% | 4,935 | $6K | |
| 0054A | <1% | 137 | $5K | |
| 90715 | <1% | 453 | $5K | |
| 86780 | <1% | 427 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 697 | $5K |
| 0004A | <1% | 157 | $5K | |
| 83655 | <1% | 422 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 185 | $4K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 365 | $4K |
| 90480 | <1% | 189 | $4K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 194 | $4K |
| 90670 | <1% | 2,046 | $4K | |
| 36416 | <1% | 1,429 | $4K | |
| 81001 | <1% | 1,351 | $4K | |
| 87081 | <1% | 855 | $4K | |
| 96127 | <1% | 941 | $3K | |
| 81514 | <1% | 12 | $3K | |
| 0124A | <1% | 90 | $3K | |
| 86803 | <1% | 188 | $3K | |
| 85018 | <1% | 1,158 | $2K | |
| 0071A | <1% | 74 | $2K | |
| 99402 | <1% | 46 | $2K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 44 | $2K |
| 90734 | <1% | 372 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 265 | $2K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 39 | $2K |
| 87338 | <1% | 121 | $2K | |
| 90656 | <1% | 177 | $2K | |
| 80050 | General health panel | <1% | 33 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 440 | $2K |
| 90837 | Psychotherapy session, about an hour | <1% | 14 | $2K |
| 0072A | <1% | 36 | $1K | |
| 0052A | <1% | 36 | $1K | |
| 99177 | <1% | 367 | $1K | |
| 90677 | <1% | 142 | $1K | |
| 81003 | <1% | 667 | $1K | |
| 87807 | <1% | 82 | $1K | |
| 0051A | <1% | 25 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 15 | $839.17 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 24 | $838.00 |
| 97802 | <1% | 12 | $825.73 | |
| 90716 | <1% | 690 | $720.97 | |
| 86140 | <1% | 137 | $720.91 | |
| 87210 | <1% | 158 | $692.81 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 60 | $576.81 |
| 84439 | <1% | 71 | $570.75 | |
| 92588 | <1% | 26 | $545.42 | |
| 82728 | <1% | 53 | $501.33 | |
| 90694 | <1% | 35 | $460.00 | |
| 92341 | <1% | 13 | $429.59 | |
| 90707 | <1% | 394 | $416.18 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 39 | $402.45 |
| 69210 | <1% | 14 | $370.81 | |
| 87340 | <1% | 30 | $298.50 | |
| 92579 | <1% | 13 | $225.82 | |
| 93793 | <1% | 84 | $225.40 | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 19 | $219.13 |
| 83540 | <1% | 36 | $216.16 | |
| 96381 | <1% | 15 | $207.11 | |
| 83550 | <1% | 24 | $188.50 | |
| 90653 | <1% | 44 | $162.02 | |
| 90688 | <1% | 18 | $114.54 | |
| 82043 | <1% | 17 | $89.76 | |
| 99442 | <1% | 17 | $73.29 | |
| 85610 | <1% | 59 | $68.30 | |
| 85652 | <1% | 40 | $38.59 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 30 | $2.66 |
| 90723 | 0% | 1,423 | $0.00 | |
| 90647 | 0% | 1,320 | $0.00 | |
| 99000 | 0% | 12 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 178 | $0.00 |
| 90696 | 0% | 87 | $0.00 | |
| 90681 | 0% | 467 | $0.00 | |
| 90633 | 0% | 952 | $0.00 | |
| 91300 | 0% | 53 | $0.00 | |
| 90700 | 0% | 51 | $0.00 | |
| 91321 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTALLARICO, DOMINICA (COO)
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Saint Paul, MN | $118.02M |
| Allina Health System | Coon Rapids, MN | $22.13M |
| Allina Health System | Minneapolis, MN | $18.26M |
| Allina Health System | Cambridge, MN | $13.17M |
| Allina Health System | St Paul, MN | $10.77M |
| Allina Health System | New Ulm, MN | $7.47M |
| Allina Health System | Fridley, MN | $7.34M |
| Allina Health System | Woodbury, MN | $5.49M |
| Allina Health System | Minneapolis, MN | $5.35M |
| Allina Health System | Bloomington, MN | $4.38M |
| Allina Health System | Northfield, MN | $4.36M |
| Allina Health System | Hastings, MN | $4.22M |
| Allina Health System | Maplewood, MN | $4.15M |
| Allina Health System | West St Paul, MN | $3.64M |
| Allina Health System | Cottage Grove, MN | $3.63M |
| Allina Health System | Minneapolis, MN | $3.54M |
| Allina Health System | Eagan, MN | $3.39M |
| Allina Health System | St Paul, MN | $3.35M |
| Allina Health System | Shakopee, MN | $2.81M |
| Allina Health System | Eden Prairie, MN | $2.71M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.